In-hospital clinical complications of COVID-19: a brief overview.
作者信息
John Kevin John, Nayar Jemimah, Mishra Ajay Kumar, Selvaraj Vijairam, Khan Mohammad Saud, Lal Amos
机构信息
Department of Critical Care, Believers Church Medical College Hospital, Thiruvalla, Kerala, India.
Department of Nuclear Medicine, Christian Medical College, Vellore, India.
出版信息
Future Virol. 2021 Oct. doi: 10.2217/fvl-2021-0200. Epub 2021 Nov 4.
Abstract
摘要
相似文献
1
In-hospital clinical complications of COVID-19: a brief overview.新型冠状病毒肺炎的院内临床并发症：简要概述
Future Virol. 2021 Oct. doi: 10.2217/fvl-2021-0200. Epub 2021 Nov 4.
2
Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry.新冠疫情时代的急性心肌梗死：发生率、临床特征和住院结局——一项多中心注册研究。
PLoS One. 2021 Jun 18;16(6):e0253524. doi: 10.1371/journal.pone.0253524. eCollection 2021.
3
Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study.COVID-19 肺癌患者住院死亡率的临床特征和危险因素：一项多中心、回顾性、队列研究。
Thorac Cancer. 2021 Jan;12(1):57-65. doi: 10.1111/1759-7714.13710. Epub 2020 Nov 3.
4
Multicenter Study of Temporal Changes and Prognostic Value of a CT Visual Severity Score in Hospitalized Patients With Coronavirus Disease (COVID-19).多中心研究：住院的新型冠状病毒肺炎（COVID-19）患者 CT 视觉严重程度评分的时间变化及其预后价值。
AJR Am J Roentgenol. 2021 Jul;217(1):83-92. doi: 10.2214/AJR.20.24044. Epub 2020 Sep 9.
5
Chronic Cardio-Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID-19: A Multicenter, Retrospective, and Real-World Study.慢性心代谢疾病增加 COVID-19 住院患者预后不良的风险：一项多中心、回顾性、真实世界研究。
J Am Heart Assoc. 2021 Jun 15;10(12):e018451. doi: 10.1161/JAHA.120.018451. Epub 2021 Jun 5.
6
Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.分析 161 例重症和危重症 COVID-19 患者的临床特征和结局：一项多中心描述性研究。
J Clin Lab Anal. 2020 Sep;34(9):e23415. doi: 10.1002/jcla.23415. Epub 2020 Jun 2.
7
8
Early resuscitation orders in hospitalized oldest-old with COVID-19: A multicenter cohort study.COVID-19 住院超高龄患者的早期复苏医嘱：一项多中心队列研究。
Palliat Med. 2021 Jul;35(7):1288-1294. doi: 10.1177/02692163211018342. Epub 2021 May 24.
9
Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.空腹血糖受损和糖尿病与 2019 冠状病毒病患者的并发症和死亡率升高相关。
Front Endocrinol (Lausanne). 2020 Jul 10;11:525. doi: 10.3389/fendo.2020.00525. eCollection 2020.
10
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.中国 COVID-19 不良临床结局的危险因素：一项多中心、回顾性、观察性研究。
Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020.
引用本文的文献
1
The impact of systemic sclerosis on hospitalized COVID-19 patients: Analysis of the US nationwide inpatient sample (2021).系统性硬化症对住院COVID-19患者的影响：美国全国住院患者样本分析（2021年）
J Scleroderma Relat Disord. 2025 May 20:23971983251342065. doi: 10.1177/23971983251342065.
2
The mortality and acute complications of large vessel vasculitis patients hospitalized with COVID-19 in the US: a nationwide inpatient sample analysis (2020).美国新冠肺炎住院大血管血管炎患者的死亡率和急性并发症：一项全国住院患者样本分析（2020年）
Rheumatol Int. 2025 Feb 22;45(3):59. doi: 10.1007/s00296-025-05811-9.
3
Altered brain glucose metabolism in COVID-19 disease: an activation likelihood estimation meta-analysis of PET studies.新冠病毒疾病中大脑葡萄糖代谢的改变：一项基于PET研究的激活可能性估计荟萃分析
Brain Imaging Behav. 2025 Apr;19(2):313-322. doi: 10.1007/s11682-025-00966-2. Epub 2025 Jan 24.
4
Frequency and Association of Polymorphisms in F2, F7, and PROS1 Coagulation Genes with Disease Severity in Coronavirus Disease 2019.F2、F7 和 PROS1 凝血基因多态性与 2019 年冠状病毒病疾病严重程度的频率及关联。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241295731. doi: 10.1177/10760296241295731.
5
Mortality Rate and Outcomes of Omicron Variant Positive Patients with Osteoporotic Fractures: A Retrospective Study.感染奥密克戎变异株的骨质疏松性骨折患者的死亡率及预后：一项回顾性研究
J Bone Metab. 2024 Feb;31(1):40-47. doi: 10.11005/jbm.2024.31.1.40. Epub 2024 Feb 29.
6
Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States.美国2019冠状病毒病相关肺曲霉病的发病率及住院治疗结果
Ann Thorac Med. 2024 Jan-Mar;19(1):87-95. doi: 10.4103/atm.atm_190_23. Epub 2024 Jan 25.
7
ProtekDuo percutaneous ventricular support system-physiology and clinical applications.ProtekDuo经皮心室支持系统——生理学与临床应用
Ann Transl Med. 2024 Feb 1;12(1):14. doi: 10.21037/atm-23-1734. Epub 2023 Dec 4.
8
A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study.对 COVID-19 病死率及其季节性趋势的时间序列回顾，以及对美国 Delta 和奥密克戎浪潮期间全因死亡率和住院治疗的调查：一项回顾性队列研究。
Front Public Health. 2023 Sep 15;11:1143650. doi: 10.3389/fpubh.2023.1143650. eCollection 2023.
9
Presentation and outcome of myocardial infarction with non-obstructive coronary arteries in coronavirus disease 2019.2019冠状病毒病合并非阻塞性冠状动脉心肌梗死的临床表现及预后
World J Crit Care Med. 2022 May 9;11(3):129-138. doi: 10.5492/wjccm.v11.i3.129.
10
A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection.采用结构同源性方法鉴定 SARS-CoV-2 感染后的潜在交叉反应性抗体反应。
Sci Rep. 2022 Jul 6;12(1):11388. doi: 10.1038/s41598-022-15225-3.
本文引用的文献
1
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.利用 ISARIC WHO 临床特征协议 UK 对 COVID-19 相关院内并发症进行特征描述：一项前瞻性、多中心队列研究。
Lancet. 2021 Jul 17;398(10296):223-237. doi: 10.1016/S0140-6736(21)00799-6.
2
COVID-19 and Myositis: What We Know So Far.COVID-19 与肌炎：目前我们所了解的。
Curr Rheumatol Rep. 2021 Jul 3;23(8):63. doi: 10.1007/s11926-021-01023-9.
3
Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury-The Current State of Knowledge and Future Perspectives.新型冠状病毒病相关急性肾损伤的病理生理学和临床表现——现有知识和未来展望。
Int J Mol Sci. 2021 Jun 30;22(13):7082. doi: 10.3390/ijms22137082.
4
Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.肾素-血管紧张素-醛固酮系统阻滞剂使用与冠状病毒病患者急性肾损伤风险增加：系统评价和荟萃分析。
Sci Rep. 2021 Jun 30;11(1):13588. doi: 10.1038/s41598-021-92323-8.
5
Barotrauma during non-invasive ventilation for acute respiratory distress syndrome caused by COVID-19: a balance between risks and benefits.COVID-19 导致的急性呼吸窘迫综合征患者行无创通气时发生气压伤：风险与获益的平衡。
Br J Hosp Med (Lond). 2021 Jun 2;82(6):1-9. doi: 10.12968/hmed.2021.0109. Epub 2021 Jun 30.
6
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究（COSMIC），报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
7
A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.新型冠状病毒感染患者的神经病变综述。
Med Sci Monit. 2021 Jun 19;27:e932962. doi: 10.12659/MSM.932962.
8
Case of erythema multiforme/Stevens-Johnson syndrome: an unusual presentation of COVID-19.COVID-19 导致的多形红斑/史蒂文斯-约翰逊综合征：一种不常见的表现。
J R Coll Physicians Edinb. 2021 Jun;51(2):160-161. doi: 10.4997/JRCPE.2021.214.
9
Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic.新型冠状病毒肺炎的皮肤表现：特征、发病机制及皮肤病学在疫情中的作用
Cutis. 2021 Apr;107(4):209-215. doi: 10.12788/cutis.0230.
10
Cerebral venous thrombosis in COVID-19.COVID-19 相关脑静脉血栓形成。
Diabetes Metab Syndr. 2021 May-Jun;15(3):1039-1045. doi: 10.1016/j.dsx.2021.04.026. Epub 2021 May 18.
Zotero 插件